Webinar: Correlation between the microbiome and metabolic syndrome
5:30pm – Thu 22 June 2017
Metabolic syndrome and its associated co-morbidites such as obesity, type 2 diabetes and non-alcoholic fatty liver disease are increasing world wide and pose a significant burden on healthcare systems. A genetic inheritance for developing such conditions is minimal and while poor dietary habits such as high fat diets certainly contribute to metabolic syndrome, it does not cause disease in isolation. The human gastrointestinal tract (GIT) harbours the most diverse and dense population of commensal bacteria, which significantly influence the metabolic activity of the human body due to the extensive genome of the bacteria. Gastrointestinal dysbiosis and permeability are associated with metabolic syndrome and contributes to insulin resistance, a key factor.
This presentation will introduce the conceptual role of bacteria both contributing to metabolic syndrome and also improving symptomology. Understanding the metabolic capacity of GIT bacteria is the next step of personalised health and nutrition.